Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Xiangyu Medical CoSHSE:688626 -0.80%91 EBITDA Margin % is 9.55% as of Jun. 2026, which is 69% below its 10-year median of 30.55. GuruFocus rates SHSE:688626 with a GF Score™ of 91/100 and a GF Value™ of ¥46.28 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 814 Medical Devices & Instruments companies, Xiangyu Medical Co ranks better than 54.55% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Xiangyu Medical Co's EBITDA for the
three
months ended in Jun. 2026 was ¥17.2 Mil. Xiangyu Medical Co's Revenue for the
three
months ended in Jun. 2026 was ¥180.1 Mil. Therefore, Xiangyu Medical Co's EBITDA margin for the quarter that ended in Jun. 2026 was 9.55%.
Xiangyu Medical Co (SHSE:688626) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Xiangyu Medical Co EBITDA Margin % Related Terms
Xiangyu Medical Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Xiangyu Medical Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688626 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Xiangyu Medical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xiangyu Medical Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Xiangyu Medical Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Xiangyu Medical Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xiangyu Medical Co (SHSE:688626) has a EBITDA Margin % of 9.55% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Xiangyu Medical Co and its competitors. This is 69% below median its historical median of 30.55. Over the past decade, Xiangyu Medical Co's EBITDA Margin % has ranged from 10.64 to 47.17. According to the industry distribution chart, Xiangyu Medical Co ranks #370 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 45.5%.
Is Xiangyu Medical Co's EBITDA Margin % too high?
Xiangyu Medical Co's current EBITDA Margin % of 9.55% is 69% below median its 10-year median of 30.55. Over the past 10 years, this metric has ranged from a low of 10.64 to a high of 47.17. The Medical Devices & Instruments industry median EBITDA Margin % is 7.98. Xiangyu Medical Co's value of 9.55% is 19.7% above this industry median. Based on the distribution chart, Xiangyu Medical Co ranks #370 out of 814 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Xiangyu Medical Co has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Xiangyu Medical Co's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Xiangyu Medical Co ranks #370 out of 814 companies for EBITDA Margin %. This puts Xiangyu Medical Co in the upper half of its industry. The industry median EBITDA Margin % is 7.98. Xiangyu Medical Co's value of 9.55% is 19.7% above this benchmark. Historically, Xiangyu Medical Co's own EBITDA Margin % has ranged from 10.64 to 47.17 over the past decade. While the company's 10-year median is 30.55 vs. the industry median of 7.98, Xiangyu Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.98, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xiangyu Medical Co's current EBITDA Margin % of 9.55% is 19.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Xiangyu Medical Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xiangyu Medical Co's current EBITDA Margin % is 9.55%, which is 69% below median its own 10-year median of 30.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xiangyu Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Xiangyu Medical Co (SHSE:688626) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥46.28, compared to a current price of ¥39.76 — trading 14.1% below its estimated fair value. The current EBITDA Margin % is 9.55%, which is 69% below median its 10-year median of 30.55 and 19.7% above the Medical Devices & Instruments industry median of 7.98. Xiangyu Medical Co's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Xiangyu Medical Co (SHSE:688626), the current EBITDA Margin % is 9.55% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Xiangyu Medical Co (SHSE:688626) Overvalued in 2026?
Based on GuruFocus' analysis, Xiangyu Medical Co stock appears to be undervalued.
The current stock price of ¥39.76 is trading 14.1% below its estimated GF Value™ of ¥46.28.
GuruFocus considers Xiangyu Medical Co to be Modestly Undervalued.
Key valuation signals for SHSE:688626:
EBITDA Margin %: 9.55% (69% below median its 10-year median of 30.55)
GF Value™: ¥46.28 vs. price of ¥39.76 (14.1% below fair value)
Industry Position: 19.7% above the Medical Devices & Instruments median (#370 of 814)
No single metric tells the full story. See the SHSE:688626 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Xiangyu Medical Co Ltd is engaged in independent research and development, production and sales of intelligent rehabilitation equipment in the fields of pain rehabilitation, neurorehabilitation, orthopedics rehabilitation, postpartum rehabilitation, and medical care integration. The company's products are divided into three categories: rehabilitation assessment, rehabilitation training, and rehabilitation physiotherapy.
91GF Score
Get the complete analysis for SHSE:688626
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688626 has been successfully added to your 
